The MEDICALIP Project: Toward the screening of the cytomegalovirus

Abstract : ince rubella vaccine was established, cytomegalovirus infection has become the most frequent cause of congenital infections. The French Health Authority is urging a diagnosis at birth for newborns. Since no screening device is commercially available, a consortium has been established to set-up an original device. The project has been funded by the French National Research Agency. The device consists of a disposable cartridge containing the biological sample and the reactive liquids required for immuno-fluorescencence detection on a functionalized surface. It also consists of a mobile reader used to drive the fluids onto the biosensor and to ensure the optical measurement. Positive and negative samples can be discriminated with a fluorescence intensity ratio of 3.
Document type :
Journal articles
Complete list of metadatas
Contributor : Sarah Djaouti <>
Submitted on : Tuesday, April 5, 2011 - 5:43:00 PM
Last modification on : Monday, April 29, 2019 - 4:27:42 PM



B. Wacogne, J.-S. Guerrini, T. Mangeat, H. Benalia, C. Pieralli, et al.. The MEDICALIP Project: Toward the screening of the cytomegalovirus. Biomedical Engineering, Springer Verlag, 2011, 32 (2), pp.66-68. ⟨10.1016/j.irbm.2011.01.022⟩. ⟨hal-00583473⟩



Record views